Webhealth Logo

A Network Connecting Health Care Professionals
Connecting Millions Of MDs, Hospitals and Clinics

sign up

log in

Webhealth Logo
  • Home
  • HealthCare Pros
    • US Medical Doctor Directory
    • US Nurse Directory
    • Sign Up or Log In
  • HealthCare Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Videos
  • Solutions
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Anemia, Refractory, with Excess of Blasts - 25 Studies Found

Status Study
Recruiting Study Name: Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Condition: Myelodysplastic Syndrome MDS Refract
Date: 2015-09-25
Interventions: Drug: rigosertib Patients will
Recruiting Study Name: Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
Condition: Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome
Date: 2015-07-27
Interventions: Drug: Azacitidine Given intrav
Active, not recruiting Study Name: Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
Condition: Myelodysplastic Syndromes Refractory Anemia With Excess Blasts
Date: 2013-08-21
Interventions: Drug: rigosertib sodium Other Names: ON 01910.Na SyB L-1101
Active, not recruiting Study Name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia
Date: 2013-04-12
Interventions: Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401
Recruiting Study Name: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi
Date: 2013-01-02
Interventions: Drug: Fludarabine phosphate Gi
Terminated Study Name: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Condition: Acute Myeloid Leukemia (AML) Acute Promyelocytic Leukemia (APL)
Date: 2011-10-28
Completed Study Name: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Condition: Acute Lymphoid Leukemia Acute Myeloid Leukemia
Date: 2011-10-24
Interventions: Drug: brentuximab vedotin 1.8
Completed Study Name: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission
Date: 2010-08-03
Interventions: Procedure: umbilical cord blood transplantation
Completed Study Name: Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7)
Date: 2010-06-16
Interventions: Other: laboratory biomarker analysis Correlative studies
Terminated Study Name: Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
Condition: Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Mye
Date: 2008-12-15
Interventions: Biological: GM-K562/leukemia cell vaccine Cultured cell line genetically changed to secrete GM-CSF mixed
Page 1 of 3
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.